let hair rais estimate flawless deal
updat model post-flawless acq/rais pt w/a favor view
deal sale compound-annual-growth-rate becom increasingli import area
portfolio hair care ep remain high end
yoy guid deal catalyst rear-view ep visibl remain high
result strong ev/ulfcf multipl attract vs average
rais estim price incorpor acquisit flawless
rais ep acquisit flawless women electr hair
remov product updat ep toward high end
yoy guidanc reiter materi ep impact expect
accret incl interest/amort gener off-set drag
cost howev importantli deal accret cash earn lt
org sale outlook increas flawless sale expect
grow rate
flawless look continu recent success increasingly-import hair
flawless add grow hair care portfolio sale follow acq
batist dri shampoo toppik hair fiber vivisc hair thin
supplement flawless momentum evid product year play
on-trend w/ look-consci consum attract product pipelin distribut
opportun intern us food healthi double-digit growth hair care
portfolio suggest bp contribut co org sale growth on-
trend brand alon intermedi term
uniqu deal structur help grow busi beyond earli inning
acquisit includ earn-out payment conting upon sale
target repres least sale compound-annual-growth-rate end later deal
structur retain lead management next three year categori still
form stage deal uniqu structur rel other
bring togeth entrepreneuri strength idea villag scale/intl
expect solid result may remain hold
est org sale ep in-lin w/co guide/consensu nonetheless
firm path achiev guid given strong us nielsen trend
continu momentum potenti upsid flawless
remain core hold given strong management team ii strong option target/
convers vs peer spd/intl inflect sale drive pt
org sale vi attract valuat ev/ulfcf vs hpc
average pt base fundamental/strateg ev/ulfcf
ev/ebitda
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
good manag team strong track record
best option group target acquir
offer compel top-line synergi multi-national
acquir view
potenti compani strong track record
organ sale growth
bp om expans bp om
expans
organ oi growth modest benefit share
repurchas drive fx-neutral ep growth
market price chanc get acquir
price target ev/ulfcf
ntm ulfcf ev/ebitda
bp top-line volum upsid improv macro share
gain key initi
bp gross margin upsid laundri compact
get acquir multi-national peer compel
price target ev/ebitda
bp top-line volum downsid share loss
bp sg increas higher invest level fend
competit pressur
bp gm headwind commod cost inflat
price target ev/ulfcf
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
chart term deal includ earnout
conting upon meet growth target impli purchas
price ebitda
chart flawless compris sale ebitda
pro-forma basi
chart acquist flawless expect accret
overal ebitda margin
chart estim flawless may add bp top-line
growth next three year
chart introduct flawless summer flawless
brow summer drove signific growth compani
chart flawless acquisit expect neutral
ep expect accret cash ep
pleas see import disclosur inform page report
thesi chart
chart deliv lt org sale growth vs
target aid new unit dose offer strong intenational growth
higher growth recent deal waterpik flawless
chart specialti repres underappreci
growth driver mix growth next
chart consist deliv street ep
estim reflect compani high degre earn
chart driven bp margin expans
sinc ahead bp stapl average expect bp
organ next year
chart less like near-term post-flawless see potenti
ep accret variou deal scenario
chart chd valuat attract given widen growth
gap vs peer better ep visibl superior option
pleas see import disclosur inform page report
